Performing Angle Viscodissection With Phaco Surgery Reduces IOP In Glaucoma Patients

Wednesday, September 17, 2008

Comments

Ocular Surgery News

The addition of viscodissection during phacoemulsification can help significantly reduce IOP and medications in narrow-angle and angle-closure glaucoma patients while maintaining good visual outcomes, an 8-year study found.

Full Story

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. Bevacizumab (Avastin)
5. All of the above
Check The Answer

Smartphone-Based Retinal Screening System
D-EYE, The Modern Day Digital ... view product
OPMI LUMERA 700 Surgical Microscope
OPMI LUMERA 700 Incorporating the latest... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Performing Angle Viscodissection With Phaco Surgery Reduces IOP In Glaucoma Patients

Comments

Related Categories

Glaucoma Testing Equipment / Glaucoma Products »

Cataract Products and Equipment »

Quick Quiz

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?

AdGlare RMR Ad

Cataract Featured Products

Smartphone-Based Retinal Screening System

OPMI LUMERA 700 Surgical Microscope

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us